Federated Intelligence

Contribute to the adversarial validation layer powering verified biopharma intelligence

The FHIN is the verified signal network beneath AimwellBio's adversarial validation layer. Healthcare does not have an information problem. It has a signal-trust problem, and this is the layer being built to fix it. Submit validated datasets. Earn credits. Every contribution challenges AI-generated science before it reaches a regulatory filing.

Public-source signal architecture Every FHIN signal traces to a primary public-source institution, FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, USPTO, or EMA. AimwellBio does not generate or infer signals; it indexes, deduplicates, and confidence-scores from authoritative registries.
Join the FHIN Contributor Network → Member Sign In →
Three questions every healthcare leader is asking
  1. 01What happens when clinical teams rely on intelligence no expert has reviewed?
  2. 02How should healthcare verify what AI produces before it reaches decision-makers?
  3. 03What signal would you want surfaced earlier in your own field?
FHIN is
  • ✓  A verified network of credentialed contributors who submit, review, and score signal data
  • ✓  The human layer beneath the adversarial validation engine, expert review at scale
  • ✓  A structured way to earn credit for the intelligence work you are already doing
  • ✓  Open to healthcare professionals, researchers, and regulatory experts who meet eligibility criteria
FHIN is not
  • ✗  A data marketplace, you retain rights to your intellectual property
  • ✗  Open to the general public without credential verification
  • ✗  A publishing platform, contributions are used for validation, not public attribution
  • ✗  A replacement for peer review, FHIN signals inform the validation layer, not journal submission
Observer vs. FHIN, what is the difference?
Observer (free) Read-access to the AimwellBio intelligence layer. For credentialed healthcare professionals who want to stay current on AI-generated biopharma science, without committing to contribute. No submission required. Apply for Observer access →
FHIN Contributor (earned) Active participation in the signal verification layer. You submit datasets, review claims, or score intelligence outputs. Contributions earn credits redeemable for premium access and a citation-eligible member badge. Requires credential review.
Who qualifies to contribute
Clinical & Research MD, DO, PhD, PharmD, or equivalent with active institutional affiliation or verifiable research history
Regulatory & Medical Affairs Experience in FDA, EMA, or equivalent regulatory submissions, or active medical affairs role at a biopharma organization
Health Economics & Outcomes HEOR specialists, health economists, or outcomes researchers with published work or institutional record
Not sure if you qualify? Start with Observer access, free for all credentialed professionals. Contributor eligibility is reviewed after application. Apply as Observer →
AW · FHINFEDERATED HEALTH INTELLIGENCE NETWORK
FHIN CORE AMC·A AMC·B RESEARCH ACADEMIC PHARMA·A PHARMA·B BIOPHARMA FDA EMA MOH·KSA REGISTRY BIORXIV FEDERATED HEALTH INTELLIGENCE NETWORK 12 institutional nodes · 4 regulatory feeds · 1 verdict pipeline REC · ACTIVE AS OF MAY 2026
12 institutional nodes · 4 regulatory feeds · 1 verdict pipeline
The Network

How the Network Works

Our streamlined contribution process is designed to uphold data quality at every step. From submission to verification to public availability.

1

Register

Create your contributor profile and select your tier based on contribution capacity.

2

Submit Data

Submit datasets with full metadata, methodology documentation, and regulatory compliance details. Provide data sources and access links for review.

3

Quality Scoring

Automated and human review assigns comprehensive quality metrics. Feedback provided for improvements.

4

Earn Credits

Approved datasets generate credits monthly based on usage and quality. Redeemable for platform access.

Participation Tiers

Choose Your Participation Level

We recognize different contribution capacities. Scale up as your organization grows.

Entry Level

Reader

Access to approved datasets. Perfect for researchers and analysts getting started.

  • 5 concurrent dataset downloads
  • Monthly quality reports
  • Community forum access
  • Email support
Core

Submitter

Submit and earn. Ideal for active researchers and small institutional teams.

  • Unlimited submissions (up to 10/month)
  • Regularly updated quality scoring
  • Credits: 100/dataset (approved)
  • 25% discount on platform services
  • Priority support
Recommended

Validator

Heavy contributors. For institutions running clinical trials and research programs.

  • Up to 50 concurrent submissions
  • API integration for bulk upload
  • Credits: 150/dataset (approved)
  • 40% discount on platform services
  • Dedicated account manager
  • Custom analytics dashboard
Enterprise

Network Anchor

Full network access. For pharmaceutical companies and healthcare systems.

  • Unlimited submissions & downloads
  • Direct data integration API
  • Credits: 200+/dataset (volume-based)
  • 60% discount on platform services
  • White-label dashboard available
  • Regulatory compliance support
Founding Cohort · Applications Open

The FHIN is in its founding cohort phase.

The first approved contributors set the verification norms, shape the credentialing standards, and receive founding-tier benefits that lock in permanently. This is not a waitlist. Applications are reviewed within 48 hours and the network is being built now. If a verification layer for healthcare intelligence is going to exist, would you rather help define its standard or subscribe to it later?

Network Status · Founding Phase
  • ✓  Applications are open, no waitlist, reviewed within 48 hours
  • ✓  Credential verification required, healthcare professionals, researchers, regulatory experts
  • ✓  Founding contributor benefits, locked in at enrollment, not available to later cohorts
  • ✓  Network size not publicly disclosed, we do not inflate counts. Verified contributor total is available to qualified institutional partners under NDA.
Apply as Founding Contributor → Existing Member? Sign In →

What happens next: Applications are reviewed within 48 hours. Approved contributors receive immediate network access and onboarding materials by email.

Questions? Contact corporate@aimwellbio.com